Providers call for broader antipsychotic exclusions to help reduce schizophrenia diagnoses
By
Kimberly Marselas
Mar 31, 2023
Providers and quality experts are questioning why the agency hasn’t done more to review its quality measure for antipsychotic drug use.
Clinical briefs for Tuesday, March 7
By
Alicia Lasek
Mar 06, 2023
Resident falls account for 75% of insurance claims with payment in senior living … States track fallout from nurse licensing scam to more LTC facilities … FDA grants priority review for Alzheimer’s...
Clinical briefs for Monday, March 6
By
Alicia Lasek
Mar 04, 2023
Providers pepper CMS with schizophrenia questions in ‘open door’ call … Home-based cardiac rehab linked to lower mortality rates … FDA sets goal to have flu and COVID combo vaccine ready in 2024...
With scope unknown, nursing homes brace for new schizophrenia audits
By
Kimberly Marselas
Feb 10, 2023
Three weeks after federal officials announced they would begin auditing nursing homes for overuse of schizophrenia diagnoses, providers are still looking for answers about what those investigations will...
Speciality care use falls after nursing home admission: report
By
Alicia Lasek
Jan 30, 2023
Visits drop steeply across multiple specialties after a nursing home admission, investigators say. For those with severe mental illness, visits fell by a whopping 67%.
CMS to begin audits for schizophrenia coding, says citations will affect quality ratings
By
Alicia Lasek
Jan 19, 2023
The agency will start auditing nursing homes this month to determine whether residents’ schizophrenia diagnoses are accurate and appropriately coded. A pattern of inaccurate coding may result in a quality...
CMS, OIG agree on increasing scrutiny of psychotropic drug use
By
Joe Bush
Nov 18, 2022
The Centers for Medicare & Medicaid Services will be increasing its oversight of the use of psychotropic drugs to pay closer attention to certain classes, warned the lead author of a federal report identifying...
Clinical briefs for Wednesday, Aug. 17
By
Alicia Lasek
Aug 17, 2022
Makers of new class of schizophrenia drug expect to file for FDA approval … Precancerous skin lesions common among Medicare beneficiaries: study … Triple therapy halves mortality in patients with severe...
Under-65 population with serious mental illness continues to grow in nursing homes, analysis finds
By
Alicia Lasek
Dec 06, 2021
SNF directors of nursing say this influx of untraditional residents, many of whom have no appropriate discharge setting, poses care challenges.
CMS program had unintended outcome for Black residents with dementia, study suggests
By
Alicia Lasek
Oct 01, 2021
The rate of schizophrenia diagnoses rose significantly for Black nursing home residents with dementia after the CMS National Partnership to Improve Dementia Care launched in 2012, a new analysis finds.